» Articles » PMID: 741207

Plasma C-peptide in Uraemic Patients

Overview
Publisher Informa Healthcare
Specialty Science
Date 1978 Dec 1
PMID 741207
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The kidney has been suggested as the main organ for the degradation of C-peptide. This hypothesis was tested in subjects with normal fasting blood glucose concentration and varying degrees of renal failure. Forty-nine subjects with endogenous creatinine clearance ranging from 0--25 ml/min were studied. The basal steady state concentrations of C-peptide (CP) and the immunoreactivity of insulin (IRI) were determined in plasma from fasting patients. The average IRI was similar to that found in normal subjects while a higher CP was found in all patients but two. The average CP in the nephrectomized patients was six times higher than the mean CP in normal subjects (0.35 pmol/ml). There was a significant inverse correlation between clearance and CP (r = 0.51, P less than 0.001) with the highest CP in nephrectomized patients. It is concluded that the increased CP in renal failure, and especially the markedly increased CP in the nephrectomized group supports the hypothesis of the kidney being the organ mainly responsible for the degradation of C-peptide also in man.

Citing Articles

Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes.

Otsuki H, Kosaka T, Nakamura K, Shimomura F, Kuwahara Y, Tsukamoto T Int Urol Nephrol. 2013; 46(2):427-32.

PMID: 24014134 DOI: 10.1007/s11255-013-0552-6.


Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus.

Chakkera H, Bodner J, Heilman R, Mulligan D, Moss A, Mekeel K Transplant Proc. 2010; 42(7):2650-2.

PMID: 20832562 PMC: 3060052. DOI: 10.1016/j.transproceed.2010.04.065.


Serum C peptide level and renal function in diabetes mellitus.

Chowta M, Adhikari P, Chowta N, Shenoy A, DSouza S Indian J Nephrol. 2010; 20(1):25-8.

PMID: 20535267 PMC: 2878407. DOI: 10.4103/0971-4065.62093.


The effect of hepatitis C virus infection on insulin resistance in chronic haemodialysis patients.

Ozdemir A, Yalinbas B, Selamet U, Eres M, Turkmen F, Kumbasar F Yonsei Med J. 2007; 48(2):274-80.

PMID: 17461527 PMC: 2628131. DOI: 10.3349/ymj.2007.48.2.274.


Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation.

Nauck M, Busing M, Orskov C, Siegel E, Talartschik J, Baartz A Acta Diabetol. 1993; 30(1):39-45.

PMID: 8329730 DOI: 10.1007/BF00572873.